1. Home
  2. ULBI vs ANVS Comparison

ULBI vs ANVS Comparison

Compare ULBI & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ultralife Corporation

ULBI

Ultralife Corporation

HOLD

Current Price

$6.93

Market Cap

97.6M

Sector

Miscellaneous

ML Signal

HOLD

Logo Annovis Bio Inc.

ANVS

Annovis Bio Inc.

HOLD

Current Price

$2.56

Market Cap

111.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ULBI
ANVS
Founded
1990
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.6M
111.3M
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
ULBI
ANVS
Price
$6.93
$2.56
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.50
AVG Volume (30 Days)
60.7K
322.7K
Earning Date
06-16-2026
06-26-2026
Dividend Yield
N/A
N/A
EPS Growth
1166.67
39.39
EPS
0.09
N/A
Revenue
$164,456,000.00
N/A
Revenue This Year
$20.00
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$77.78
N/A
Revenue Growth
3.66
N/A
52 Week Low
$4.07
$1.11
52 Week High
$9.51
$5.50

Technical Indicators

Market Signals
Indicator
ULBI
ANVS
Relative Strength Index (RSI) 63.23 45.59
Support Level $6.35 $2.29
Resistance Level $7.24 $2.63
Average True Range (ATR) 0.46 0.20
MACD 0.17 0.03
Stochastic Oscillator 79.37 16.15

Price Performance

Historical Comparison
ULBI
ANVS

About ULBI Ultralife Corporation

Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

Share on Social Networks: